Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.
T Demant, … , C J Packard, J Shepherd
T Demant, … , C J Packard, J Shepherd
Published November 1, 1991
Citation Information: J Clin Invest. 1991;88(5):1490-1501. https://doi.org/10.1172/JCI115459.
View: Text | PDF
Research Article

Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.

  • Text
  • PDF
Abstract

This study examined apolipoprotein (apo) B metabolism in normolipemic subjects homozygous for the apo E2 (n = 4), apo E3 (n = 5), or apo E4 (n = 5) phenotype. Radioiodinated very low density lipoprotein (VLDL1) (ultracentrifuge flotation rate [Sf] 60-400) and VLDL2 (Sf 20-60) were injected into volunteers and the conversion of apo B was followed through intermediate density lipoprotein (IDL) to low density lipoprotein (LDL). Subjects homozygous for E3 converted approximately 50% of LVDL2 to LDL, the remainder being lost by direct catabolism. Those with the E2 phenotype produced less VLDL1, but converted more of it to VLDL2 (compared to E3 subjects). They displayed a characteristic dyslipidemia with the presence of slowly catabolized VLDL1 and VLDL2 remnants. LDL levels were low owing to increased direct catabolism of VLDL2 and IDL and a reduced efficiency of delipidation; only 25% of VLDL2 apo B was directed to LDL production. In contrast, E4 subjects converted more VLDL2 apo B to LDL than E3 subjects. About 70% of VLDL2 apo B was found in LDL; direct catabolism of VLDL and IDL was reduced as was the fractional catabolic rate of LDL (0.2 vs. 0.26 in E3 subjects). These changes in the VLDL----IDL----LDL metabolic cascade can in part be explained by alterations in hepatic LDL receptors with E2 subjects having higher and E4 subjects lower activities than those in E3 homozygotes.

Authors

T Demant, D Bedford, C J Packard, J Shepherd

×

Total citations by year

Year: 2024 2020 2019 2018 2017 2016 2014 2012 2011 2010 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 Total
Citations: 1 1 1 1 3 2 2 1 3 2 3 4 4 3 7 4 3 4 7 11 5 12 14 8 8 11 1 126
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (126)

Title and authors Publication Year
Large-scale genome-wide interaction analyses on multiple cardiometabolic risk factors to identify age-specific genetic risk factors.
Ao L, van Heemst D, Luo J, Teder-Laving M, Mägi R, Frikke-Schmidt R, Willems van Dijk K, Noordam R
GeroScience 2024
Causes and Consequences of Hypertriglyceridemia
CJ Packard, J Boren, MR Taskinen
Frontiers in Endocrinology 2020
Plasma ApoE elevations are associated with NAFLD: The PREVEND Study
EH van den Berg, JP Corsetti, SJ Bakker, RP Dullaart, P Bjornstad
PloS one 2019
APOE4 Genotype Exerts Greater Benefit in Lowering Plasma Cholesterol and Apolipoprotein B than Wild Type (E3/E3), after Replacement of Dietary Saturated Fats with Low Glycaemic Index Carbohydrates
B Griffin, C Walker, S Jebb, C Moore, G Frost, L Goff, T Sanders, F Lewis, M Griffin, R Gitau, J Lovegrove
Nutrients 2018
Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review
J Oscarsson, E Hurt-Camejo
Lipids in Health and Disease 2017
Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients
YW Jiang, L Ma, CW Han, Q Liu, X Cong, YP Xu, TT Zhao, P Li, YT Cao
Journal of Diabetes Research 2017
Plasma apolipoproteins and physical and cognitive health in very old individuals
J Muenchhoff, F Song, A Poljak, JD Crawford, KA Mather, NA Kochan, Z Yang, JN Trollor, S Reppermund, K Maston, A Theobald, S Kirchner-Adelhardt, JB Kwok, RL Richmond, M McEvoy, J Attia, PW Schofield, H Brodaty, PS Sachdev
Neurobiology of Aging 2017
Relationship between Adipokines and Lipid Profile in Postmenopausal Women with Different Apoe Genotypes
M Gibas-Dorna, J Piątek, J Kupsz, M Bernatek, H Krauss, A Sowinska, P Kołodziejski, A Owoc, I Bojar
Women & Health 2016
Omega-3 Fatty Acids
RA Brown
Omega-3 Fatty Acids 2016
Hyperlipoproteinemia Type 3: The Forgotten Phenotype
PN Hopkins, EA Brinton, MN Nanjee
Current Atherosclerosis Reports 2014
Apoliprotein E genotype is associated with apoliprotein B plasma levels but not with coronary calcium score in very elderly individuals in primary care setting
AD Henriques, AC Tonet-Furioso, W Machado-Silva, WM Freitas, LA Quaglia, SN Santos, C Córdova, AC Sposito, OT Nóbrega
Gene 2014
Apolipoprotein E4 Domain Interaction Accelerates Diet-Induced Atherosclerosis in Hypomorphic Arg-61 Apoe Mice
D Eberlé, RY Kim, FS Luk, NS de Mochel, N Gaudreault, VR Olivas, N Kumar, JM Posada, AC Birkeland, JH Rapp, RL Raffai
Arteriosclerosis, thrombosis, and vascular biology 2012
Diagnostic markers based on a computational model of lipoprotein metabolism
DB van Schalkwijk, B Ommen, AP Freidig, J der Greef, AA de Graaf
Journal of Clinical Bioinformatics 2011
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk
S Calandra, P Tarugi, HE Speedy, AF Dean, S Bertolini, CC Shoulders
Journal of lipid research 2011
Interactive effects of APOE haplotype, sex, and exercise on postheparin plasma lipase activities
RL Seip, RF Zoeller, TJ Angelopoulos, J Salonia, C Bilbie, NM Moyna, MP Miles, PS Visich, LS Pescatello, PM Gordon, GJ Tsongalis, L Bausserman, PD Thompson
Journal of applied physiology 2011
Integrated Role of Two Apoliprotein E Polymorphisms on Apolipoprotein B Levels and Coronary Artery Disease in a Biethnic Population
Z Ozturk, B Enkhmaa, NS Shachter, L Berglund, E Anuurad
Metabolic Syndrome and Related Disorders 2010
Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil
E Olano-Martin, E Anil, MJ Caslake, CJ Packard, D Bedford, G Stewart, D Peiris, CM Williams, AM Minihane
Atherosclerosis 2010
Novartis Foundation Symposia
EJ Campbell
Ciba Foundation Symposium 44 - Research and Medical Practice: Their Interaction 2008
Association of Apolipoprotein E Polymorphisms in Patients with Non-Alcoholic Steatohepatitis
A Sazci, G Akpinar, C Aygun, E Ergul, O Senturk, S Hulagu
Digestive Diseases and Sciences 2008
Personalized nutrition for the prevention of cardiovascular disease: a future perspective
JA Lovegrove, R Gitau
Journal of Human Nutrition and Dietetics 2008
Apolipoprotein E Gene Polymorphism in Nonalcoholic Fatty Liver Disease
MD Demirag, HI Onen, MY Karaoguz, I Dogan, T Karakan, A Ekmekci, G Guz
Digestive Diseases and Sciences 2007
ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation
AM Minihane, L Jofre-Monseny, E Olano-Martin, G Rimbach
Proceedings of the Nutrition Society 2007
Apolipoprotein E genotype affects the response to lipid-lowering therapy in Chinese patients with type 2 diabetes mellitus
S Tavintharan, SC Lim, YH Chan, CF Sum
Diabetes, Obesity and Metabolism 2007
Structural variation manipulates the differential oxidative susceptibility and conformational stability of apolipoprotein E isoforms
KL Su, TH Wen, CY Chou, GG Chang, GY Liu, HC Hung
Proteins: Structure, Function, and Bioinformatics 2007
The effect of apolipoprotein E genotype on serum lipoprotein particle response to exercise
RL Seip, J Otvos, C Bilbie, GJ Tsongalis, M Miles, R Zoeller, P Visich, P Gordon, TJ Angelopoulos, L Pescatello, N Moyna, PD Thompson
Atherosclerosis 2006
Influencia de los factores genéticos y ambientales en el metabolismo lipídico y riesgo cardiovascular asociado al gen apoE
JA Moreno, J López-Miranda, F Pérez-Jiménez
Medicina Clínica 2006
Apolipoprotein E polymorphism in the Tunisian population: Frequency and effect on lipid parameters
R Jemaa, M Elasmi, C Naouali, M Feki, A Kallel, M Souissi, H Sanhaji, SH Taïeb, O Souheil, N Kaabachi
Clinical Biochemistry 2006
LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes.
Murdoch SJ, Boright AP, Paterson AD, Zinman B, Steffes M, Cleary P, Edwards K, Marcovina SS, Purnell JQ, Brunzell JD
Atherosclerosis 2006
Characterisation of the lipoprotein structure in the St. Thomas’ Mixed Hyperlipidaemic (SMHL) rabbit
B Roos, MJ Caslake, K Milliner, GM Benson, KE Suckling, CJ Packard
Atherosclerosis 2005
The effect of apolipoprotein E polymorphism on lipid levels in Korean adults
MH Shin, HN Kim, LH Cui, SS Kweon, KS Park, H Heo, HS Nam, SK Jeong, EK Chung, JS Choi
Journal of Korean Medical Science 2005
Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution
CY Chou, YL Lin, YC Huang, SY Sheu, TH Lin, HJ Tsay, GG Chang, MS Shiao
Biophysical Journal 2005
Familial hypercholesterolemia in children
J Rodenburg, MN Vissers, A Wiegman, MD Trip, HD Bakker, JJ Kastelein
Current Opinion in Lipidology 2004
Metabolic abnormalities: triglyceride and low-density lipoprotein
RM Krauss, PW Siri
Endocrinology & Metabolism Clinics of North America 2004
Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function
S Kahraman, AA Kiykim, B Altun, G Genctoy, M Arici, M Gulsun, Y Erdem, U Yasavul, C Turgan, S Caglar
Clinical Transplantation 2004
Heritability of C-Reactive Protein and Association with Apolipoprotein E Genotypes in Japanese Americans
MA Austin, C Zhang, SE Humphries, WL Chandler, PJ Talmud, KL Edwards, DL Leonetti, MJ Mcneely, WY Fujimoto
Annals of Human Genetics 2004
Apolipoprotein E polymorphism in Vietnamese children and its relationship to plasma lipid and lipoprotein levels
NN Thu, TT Mai, R Ohmori, M Kuroki, NV Chuyen, NT Hung, M Kawakami, K Kondo
Metabolism 2004
Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency
K Ikewaki, W Cain, F Thomas, R Shamburek, LA Zech, D Usher, HB Brewer, DJ Rader
Journal of lipid research 2004
Hepatic Catabolism of Remnant Lipoproteins: Where the Action Is
RJ Havel, RL Hamilton
Arteriosclerosis, thrombosis, and vascular biology 2004
Influence of apolipoprotein E genotype on the response to caloric restriction in type 2 diabetic patients with hyperlipidaemia
N Tamasawa, H Murakami, K Yamato, J Matsui, J Tanabe, T Suda
Diabetes, Obesity and Metabolism 2003
A prospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men
S Liu, J Ma, PM Ridker, JL Breslow, MJ Stampfer
Atherosclerosis 2003
The Apolipoprotein ε4 Allele Confers Additional Risk in Children with Familial Hypercholesterolemia
A Wiegman, EJ Sijbrands, J Rodenburg, JC Defesche, S Jongh, HD Bakker, JJ Kastelein
Pediatric Research 2003
Association of apo E polymorphism with variations in lipid and small dense LDL in koreans with alow fat intake
MJ Shin, EY Cho, HY Park, HK Cho, JH Lee, Y Jang
Nutrition Research 2003
Gender-specific effects of apolipoprotein E genotype on plasma lipid levels in a population-based sample of 6-7-year-old children in Spain
C Garcés, M Benavente, MA Lasunción, H Ortega, G Nájera, M Oya
Acta Paediatrica 2002
Comparative in vivo metabolism of apolipoproteins E2 and E4 in heterozygous apoE2/4 subjects
K Ikewaki, LA Zech, HB Brewer, DJ Rader
Journal of Laboratory and Clinical Medicine 2002
Metabolic origins and clinical significance of LDL heterogeneity
KK Berneis, RM Krauss
Journal of lipid research 2002
Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E
AR Mensenkamp, LM Havekes, JA Romijn, F Kuipers
Journal of Hepatology 2001
Differential metabolism of human VLDL according to content of ApoE and ApoC-III
K Tomiyasu, BW Walsh, K Ikewaki, H Judge, FM Sacks
Arteriosclerosis, thrombosis, and vascular biology 2001
The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects
B de Roos, MJ Caslake, AF Stalenhoef, D Bedford, PN Demacker, MB Katan, CJ Packard
The American journal of clinical nutrition 2001
Mice Expressing Only the Mutant APOE3Leiden Gene Show Impaired VLDL Secretion
AR Mensenkamp, B Teusink, JF Baller, H Wolters, R Havinga, KW van Dijk, LM Havekes, F Kuipers
Arteriosclerosis, thrombosis, and vascular biology 2001
Association of apolipoprotein (Apo)E genotype with plasma apo E levels
IA Larson, JM Ordovas, C DeLuca, JR Barnard, G Feussner, EJ Schaefer
Atherosclerosis 2000
GENETICS OFLIPOPROTEINABNORMALITIESASSOCIATED WITHCORONARYHEARTDISEASESUSCEPTIBILITY
JL Breslow
Annual Review of Genetics 2000
Gene-diet interactions and plasma lipoproteins: Role of apolipoprotein E and habitual saturated fat intake
H Campos, M D?Agostino, JM Ordov�s
Genetic Epidemiology 2000
Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans
FK Welty, AH Lichtenstein, PH Barrett, JL Jenner, GG Dolnikowski, EJ Schaefer
Arteriosclerosis, thrombosis, and vascular biology 2000
Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E
AD Dergunov, EA Smirnova, A Merched, S Visvikis, G Siest, VV Yakushkin, V Tsibulsky
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2000
Lipoprotein Metabolism and Atherogenesis
T Kita, M Yokode
2000
Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesity
GF Watts, FM Riches, SE Humphries, PJ Talmud, FM van Bockxmeer
Journal of lipid research 2000
Apo E structure determines VLDL clearance and atherosclerosis risk in mice
C Knouff, ME Hinsdale, H Mezdour, MK Altenburg, M Watanabe, SH Quarfordt, PM Sullivan, N Maeda
Journal of Clinical Investigation 1999
Apolipoprotein E and atherosclerosis: insight from animal and human studies
J Davignon, JS Cohn, L Mabile, L Bernier
Clinica Chimica Acta 1999
Variation of apolipoprotein B as a possible cause of decreased low density lipoprotein clearance and hypercholesterolemia
T Korhonen, MJ Savolainen, YA Kesäniemi
Atherosclerosis 1999
Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins
D Gómez-Coronado, JJ Álvarez, A Entrala, JM Olmos, E Herrera, MÁ Lasunción
Atherosclerosis 1999
Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects
R Malmström, CJ Packard, M Caslake, D Bedford, P Stewart, J Shepherd, MR Taskinen
Atherosclerosis 1999
Apolipoprotein E phenotypes in hemodialysis patients
T Imura, H Kimura, F Gejyo
Kidney International 1999
Relationship between the apolipoprotein E and angiotensin-converting enzyme genotypes and LDL particle size in Japanese subjects
K Okumura, H Matsui, K Kawakami, Y Numaguchi, S Kaneko, I Morishima, S Mokuno, Y Toki, T Hayakawa
Clinica Chimica Acta 1999
Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes
FK Welty, AH Lichtenstein, PH Barrett, GG Dolnikowski, EJ Schaefer
Arteriosclerosis, thrombosis, and vascular biology 1999
Postprandial lipoprotein metabolism and atherosclerosis
F Karpe
Journal of Internal Medicine 1999
Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes
CD Mamotte, M Sturm, JI Foo, FM van Bockxmeer, RR Taylor
American journal of physiology. Endocrinology and metabolism 1999
Independent Effects of Apo E Phenotype and Plasma Triglyceride on Lipoprotein Particle Sizes in the Fasting and Postprandial States
AM Dart, B Cooper
Arteriosclerosis, thrombosis, and vascular biology 1999
Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf>60) particles
S Bioletto, P Fontana, R Darioli, RW James
Atherosclerosis 1998
Apolipoprotein E phenotype associations with plasma lipoproteins and bone mass in postmenopausal women
M Sanada, H Nakagawa, I Kodama, T Sakasita, K Ohama
Climacteric 1998
Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia
C Sanllehy, E Casals, C Rodriguez-Villar, D Zambón, J Ojuel, AM Ballesta, E Ros
Metabolism 1998
Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet
WR Fisher, LA Zech, PW Stacpoole
Journal of lipid research 1998
Apolipoprotein B signal peptide and apolipoprotein E genotypes as determinants of the hepatic secretion of VLDL apoB in obese men
FM Riches, GF Watts, FM van Bockxmeer, J Hua, S Song, SE Humphries, PJ Talmud
Journal of lipid research 1998
A dietary and behavioral intervention designed to lower coronary heart disease. Risk factors are unaffected by variation at the APOE gene locus
A Pasagian-Macaulay
Atherosclerosis 1997
Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man
FM Riches, GF Watts, RP Naoumova, JM Kelly, KD Croft, GR Thompson
Atherosclerosis 1997
DETERMINANTS OF THE KINETICS OF VERY LOW-DENSITY LIPOPROTEIN APOLIPOPROTEIN B-100 IN NON-OBESE MEN
GF Watts, FM Riches, JM Kelly, MA Powell, KD Croft
Clinical and Experimental Pharmacology and Physiology 1997
Genetic predictors of common disease: Apolipoprotein E genotype as a paradigm
GP Jarvik
Annals of Epidemiology 1997
Evidence That the Apolipoprotein E-Genotype Effects on Lipid Levels Can Change with Age in Males: A Longitudinal Analysis
GP Jarvik, EL Goode, MA Austin, J Auwerx, S Deeb, GD Schellenberg, T Reed
The American Journal of Human Genetics 1997
Heritability of Longitudinal Changes in Coronary-Heart-Disease Risk Factors in Women Twins
Y Friedlander, MA Austin, B Newman, K Edwards, EJ Mayer-Davis, MC King
The American Journal of Human Genetics 1997
Effect of Apolipoprotein E Phenotype on Plasma Lipids and Lipoproteins in Alcohol Abusers
MJ Liinamaa, K Kervinen, ML Hannuksela, YA Kesaniemi, MJ Savolainen
Alcoholism, clinical and experimental research 1997
Heritability of longitudinal changes in coronary-heart-disease risk factors in women twins
Y Friedlander, MA Austin, B Newman, K Edwards, EI Mayer-Davis, MC King
The American Journal of Human Genetics 1997
Very-low-density lipoprotein subfraction composition and metabolism by adipose tissue
RM Fisher, JM Miles, BA Kottke, KN Frayn, SW Coppack
Metabolism 1997
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism
CJ Packard, J Shepherd
Arteriosclerosis, thrombosis, and vascular biology 1997
Association of Apo E Polymorphism With Plasma Lipid Levels in a Multiethnic Elderly Population
A Pablos-Méndez, R Mayeux, C Ngai, S Shea, L Berglund
Arteriosclerosis, thrombosis, and vascular biology 1997
Lipoprotein Kinetics in Patients With Analbuminemia: Evidence for the Role of Serum Albumin in Controlling Lipoprotein Metabolism
C Maugeais, S Braschi, K Ouguerram, P Maugeais, P Mahot, B Jacotot, D Darmaun, T Magot, M Krempf
Arteriosclerosis, thrombosis, and vascular biology 1997
Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patients
EJ Sijbrands, RG Westendorp, MJ Hoffer, RR Frants, AE Meinders, JH Souverijn, JA Leuven, AV der Laarse, LM Havekes, AH Smelt
Atherosclerosis 1996
Effects of apo B and apo E gene polymorphisms on lipid and apolipoprotein concentrations after a test meal
A Regis-Bailly, S Visvikis, J Steinmetz, B Fournier, R Gueguen, G Siest
Clinica Chimica Acta 1996
Review
M Epstein
Renal Failure 1996
Triglycerides: a risk factor for coronary heart disease
J Davignon, JS Cohn
Atherosclerosis 1996
Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: Results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia
Y Friedlander, E Leitersdorf
Genetic Epidemiology 1996
The effect of physical activity on serum total and low-density lipoprotein cholesterol concentrations varies with apolipoprotein E phenotype in male children and young adults: The cardiovascular risk in young finns study
S Taimela, T Lehtimäki, KV Porkka, L Räsänen, JS Viikari
Metabolism 1996
Clinical chemistry of common apolipoprotein E isoforms
DA Brouwer, JJ van Doormaal, FA Muskiet
Journal of Chromatography B: Biomedical Sciences and Applications 1996
In the Absence of Endogenous Mouse Apolipoprotein E, Apolipoprotein E*2(Arg-158 → Cys) Transgenic Mice Develop More Severe Hyperlipoproteinemia than Apolipoprotein E*3-Leiden Transgenic Mice
BJ van Vlijmen, KW van Dijk, HB Hof, PJ van Gorp, A der Zee, H der Boom, ML Breuer, MH Hofker, LM Havekes
The Journal of biological chemistry 1996
The Underlying Molecular Mechanism of Apolipoprotein E Polymorphism: Relationships to Lipid Disorders, Cardiovascular Disease, and Alzheimer’s Disease
JH Contois, DE Anamani, GJ Tsongalis
Clinics in Laboratory Medicine 1996
Apolipoprotein E Polymorphism and LDL Size in a Biethnic Population
SM Haffner, MP Stern, H Miettinen, D Robbins, BV Howard
Arteriosclerosis, thrombosis, and vascular biology 1996
Effects of Colestipol Alone and in Combination With Simvastatin on Apolipoprotein B Metabolism
A Gaw, CJ Packard, GM Lindsay, EF Murray, BA Griffin, MJ Caslake, I Colquhoun, DJ Wheatley, AR Lorimer, J Shepherd
Arteriosclerosis, thrombosis, and vascular biology 1996
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson
1996
Triggering of Acute Coronary Syndromes
SN Willich, JE Muller
1996
Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors
K Bohnet, T Pillot, S Visvikis, N Sabolovic, G Siest
Journal of lipid research 1996
Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma
Y Huang, A Eckardstein, S Wu, G Assmann
Journal of Clinical Investigation 1995
Apolipoprotein E Isoform Phenotype and LDL Subclass Response to a Reduced-Fat Diet
DM Dreon, HA Fernstrom, B Miller, RM Krauss
Arteriosclerosis, thrombosis, and vascular biology 1995
Multiple Risk Factors in Cardiovascular Disease
AM Gotto, C Lenfant, AL Catapano, R Paoletti
1995
Cardiovascular Disease 2
LL Gallo
1995
Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism
CJ Packard, A Gaw, T Demant, J Shepherd
Journal of lipid research 1995
Molecular characterization of two monoclonal antibodies specific for the LDL receptor-binding site of human apolipoprotein E
R Raffai, R Maurice, K Weisgraber, T Innerarity, X Wang, R MacKenzie, T Hirama, D Watson, E Rassart, R Milne
Journal of lipid research 1995
Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins
A Gaw, CJ Packard, GM Lindsay, BA Griffin, MJ Caslake, AR Lorimer, J Shepherd
Journal of lipid research 1995
Association between serum lipids and apolipoprotein E phenotype is influenced by diet in a population-based sample of free-living children and young adults: the Cardiovascular Risk in Young Finns Study
T Lehtimäki, T Moilanen, K Porkka, HK Akerblom, T Rönnemaa, L Räsänen, J Viikari, C Ehnholm, T Nikkari
Journal of lipid research 1995
Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lysl46→Gln) are inefficiently converted to cholesterol-rich lipoproteins
M Mulder, H der Boom, P Kniff, C Braam, A Maagdenberg, JA Leuven, LM Havekes
Atherosclerosis 1994
Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels
P Knijff, AM van Maagdenberg, RR Frants, LM Havekes
Human Mutation 1994
Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol and triglyceride levels: Longitudinal apolipoprotein E genotype effects
GP Jarvik, MA Austin, RR Fabsitz, J Auwerx, T Reed, JC Christian, S Deeb
Genetic Epidemiology 1994
Effects of ciprofibrate on LDL metabolism in man
A Gaw, CJ Packard, MJ Caslake, BA Griffin, GM Lindsay, J Thomson, BD Vallance, D Wosornu, J Shepherd
Atherosclerosis 1994
Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study
EJ Schaefer, S Lamon-Fava, S Johnson, JM Ordovas, MM Schaefer, WP Castelli, PW Wilson
Arteriosclerosis Thrombosis and Vascular Biology 1994
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg
1994
Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol
J Lopez-Miranda, JM Ordovas, P Mata, AH Lichtenstein, B Clevidence, JT Judd, EJ Schaefer
Journal of lipid research 1994
Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia implication for lipoprotein(a) metabolism
G Lindahl, F Mailly, S Humphries, M Seed
The Clinical Investigator 1994
Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy
L Berglund, O Wiklund, G Eggertsen, SO Olofsson, M Eriksson, T Lindén, G Bondjers, B Angelin
Journal of Internal Medicine 1993
Relationship between apolipoprotein E and low density lipoprotein particle size
SP Zhao, MH Verhoeven, J Vink, L Hollaar, A der Laarse, P Knijff, FM Hooft
Atherosclerosis 1993
Different hydrolytic efficiencies of adipose tissue lipoprotein lipase on very-low-density lipoprotein subfractions separated by heparin-Sepharose chromatography
D Gómez-Coronado, GT Sáez, MA Lasunción, E Herrera
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1993
Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia
MJ Caslake, CJ Packard, A Gaw, E Murray, BA Griffin, BD Vallance, J Shepherd
Arteriosclerosis Thrombosis and Vascular Biology 1993
Effects of simvastatin on apoB metabolism and LDL subfraction distribution
A Gaw, CJ Packard, EF Murray, GM Lindsay, BA Griffin, MJ Caslake, BD Vallance, AR Lorimer, J Shepherd
Arteriosclerosis Thrombosis and Vascular Biology 1993
Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro
DA Chappell, GL Fry, MA Waknitz, LE Muhonen, MW Pladet
The Journal of biological chemistry 1993
Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia
T Demant, A Gaw, GF Watts, P Durrington, B Buckley, CW Imrie, C Wilson, CJ Packard, J Shepherd
Journal of lipid research 1993
Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype
LJ Martin, PW Connelly, D Nancoo, N Wood, ZJ Zhang, G Maguire, E Quinet, AR Tall, YL Marcel, R McPherson
Journal of lipid research 1993
Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment
P Lombardi, M Mulder, H van der Boom, RR Frants, LM Havekes
The Journal of biological chemistry 1993
Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia
KG Parhofer, PH Barrett, J Dunn, G Schonfeld
The Clinical Investigator 1993
The effect of the apolipoprotein E phenotype on plasma lipids is not influenced by environmental variability: results of a Dutch twin study
P de Knijff, DI Boomsma, E de Wit, HJ Kempen, JA Leuven, RR Frants, LM Havekes
Human Genetics 1993
Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes
TA Miettinen, H Gylling, H Vanhanen, A Ollus
Arteriosclerosis Thrombosis and Vascular Biology 1992

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts